CN108569969A - 一种间氨基苯乙炔的合成方法 - Google Patents
一种间氨基苯乙炔的合成方法 Download PDFInfo
- Publication number
- CN108569969A CN108569969A CN201710140835.0A CN201710140835A CN108569969A CN 108569969 A CN108569969 A CN 108569969A CN 201710140835 A CN201710140835 A CN 201710140835A CN 108569969 A CN108569969 A CN 108569969A
- Authority
- CN
- China
- Prior art keywords
- aminophenylacetylene
- reaction
- dimethyl phosphonate
- diazo
- nitrobenzaldehyde
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- NNKQLUVBPJEUOR-UHFFFAOYSA-N 3-ethynylaniline Chemical group NC1=CC=CC(C#C)=C1 NNKQLUVBPJEUOR-UHFFFAOYSA-N 0.000 title claims abstract description 25
- 238000010189 synthetic method Methods 0.000 title claims description 5
- 238000006243 chemical reaction Methods 0.000 claims abstract description 39
- -1 diazo, 2 oxopropyl Chemical group 0.000 claims abstract description 24
- YLFBFPXKTIQSSY-UHFFFAOYSA-N dimethoxy(oxo)phosphanium Chemical compound CO[P+](=O)OC YLFBFPXKTIQSSY-UHFFFAOYSA-N 0.000 claims abstract description 19
- ZETIVVHRRQLWFW-UHFFFAOYSA-N 3-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=CC(C=O)=C1 ZETIVVHRRQLWFW-UHFFFAOYSA-N 0.000 claims abstract description 17
- UISZKHSCSVDZMV-UHFFFAOYSA-N acetylene nitrobenzene Chemical group C#C.[N+](=O)([O-])C1=CC=CC=C1 UISZKHSCSVDZMV-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- 239000003054 catalyst Substances 0.000 claims abstract description 11
- 230000009467 reduction Effects 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 11
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 8
- 239000007858 starting material Substances 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- 235000019270 ammonium chloride Nutrition 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical group [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 5
- 235000019441 ethanol Nutrition 0.000 claims description 5
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 4
- 238000004364 calculation method Methods 0.000 claims description 4
- QTVZMDBUTVCLGX-UHFFFAOYSA-N dimethyl 2-oxopropyl phosphate Chemical compound COP(=O)(OC)OCC(C)=O QTVZMDBUTVCLGX-UHFFFAOYSA-N 0.000 claims description 4
- 239000003792 electrolyte Substances 0.000 claims description 4
- 239000012312 sodium hydride Substances 0.000 claims description 4
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- YJMNLPRMBFMFDL-UHFFFAOYSA-N n-diazo-2-methylbenzenesulfonamide Chemical compound CC1=CC=CC=C1S(=O)(=O)N=[N+]=[N-] YJMNLPRMBFMFDL-UHFFFAOYSA-N 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 claims description 2
- CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 2
- 229910021626 Tin(II) chloride Inorganic materials 0.000 claims description 2
- 150000001345 alkine derivatives Chemical class 0.000 claims description 2
- 239000012043 crude product Substances 0.000 claims description 2
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 claims description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000001119 stannous chloride Substances 0.000 claims description 2
- 235000011150 stannous chloride Nutrition 0.000 claims description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 2
- 125000001539 acetonyl group Chemical group [H]C([H])([H])C(=O)C([H])([H])* 0.000 claims 1
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 230000035484 reaction time Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Substances [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 abstract description 5
- JXMZUNPWVXQADG-UHFFFAOYSA-N 1-iodo-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1I JXMZUNPWVXQADG-UHFFFAOYSA-N 0.000 abstract description 4
- ORPVVAKYSXQCJI-UHFFFAOYSA-N 1-bromo-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1Br ORPVVAKYSXQCJI-UHFFFAOYSA-N 0.000 abstract description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 abstract description 2
- 238000003912 environmental pollution Methods 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- UEXCJVNBTNXOEH-UHFFFAOYSA-N Ethynylbenzene Chemical group C#CC1=CC=CC=C1 UEXCJVNBTNXOEH-UHFFFAOYSA-N 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 229910052794 bromium Inorganic materials 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 239000012065 filter cake Substances 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- ARKIFHPFTHVKDT-UHFFFAOYSA-N 1-(3-nitrophenyl)ethanone Chemical compound CC(=O)C1=CC=CC([N+]([O-])=O)=C1 ARKIFHPFTHVKDT-UHFFFAOYSA-N 0.000 description 2
- WWXMVRYHLZMQIG-SNAWJCMRSA-N 3-nitrocinnamic acid Chemical compound OC(=O)\C=C\C1=CC=CC([N+]([O-])=O)=C1 WWXMVRYHLZMQIG-SNAWJCMRSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 2
- 239000005551 L01XE03 - Erlotinib Substances 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 150000001448 anilines Chemical class 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000007256 debromination reaction Methods 0.000 description 2
- 238000006114 decarboxylation reaction Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- AAKJLRGGTJKAMG-UHFFFAOYSA-N erlotinib Chemical compound C=12C=C(OCCOC)C(OCCOC)=CC2=NC=NC=1NC1=CC=CC(C#C)=C1 AAKJLRGGTJKAMG-UHFFFAOYSA-N 0.000 description 2
- 229960001433 erlotinib Drugs 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- UJHSIDUUJPTLDY-UHFFFAOYSA-N (2-nitrophenyl)-phenylmethanone Chemical compound [O-][N+](=O)C1=CC=CC=C1C(=O)C1=CC=CC=C1 UJHSIDUUJPTLDY-UHFFFAOYSA-N 0.000 description 1
- MFYLRNKOXORIPK-UHFFFAOYSA-N (3-nitrophenyl)-phenylmethanone Chemical compound [O-][N+](=O)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 MFYLRNKOXORIPK-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- MJBPUQUGJNAPAZ-UHFFFAOYSA-N Butine Natural products O1C2=CC(O)=CC=C2C(=O)CC1C1=CC=C(O)C(O)=C1 MJBPUQUGJNAPAZ-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- KKUKTXOBAWVSHC-UHFFFAOYSA-N Dimethylphosphate Chemical compound COP(O)(=O)OC KKUKTXOBAWVSHC-UHFFFAOYSA-N 0.000 description 1
- 102000009465 Growth Factor Receptors Human genes 0.000 description 1
- 108010009202 Growth Factor Receptors Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 238000003684 Perkin reaction Methods 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
- 238000006223 Seyferth-Gilbert homologation reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical class ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000005695 dehalogenation reaction Methods 0.000 description 1
- 238000007269 dehydrobromination reaction Methods 0.000 description 1
- 230000005595 deprotonation Effects 0.000 description 1
- 238000010537 deprotonation reaction Methods 0.000 description 1
- GTTBEUCJPZQMDZ-UHFFFAOYSA-N erlotinib hydrochloride Chemical compound [H+].[Cl-].C=12C=C(OCCOC)C(OCCOC)=CC2=NC=NC=1NC1=CC=CC(C#C)=C1 GTTBEUCJPZQMDZ-UHFFFAOYSA-N 0.000 description 1
- 229960005073 erlotinib hydrochloride Drugs 0.000 description 1
- BCOSADJFQAVSRO-UHFFFAOYSA-N ethenediazonium Chemical compound C=C[N+]#N BCOSADJFQAVSRO-UHFFFAOYSA-N 0.000 description 1
- KDKYADYSIPSCCQ-UHFFFAOYSA-N ethyl acetylene Natural products CCC#C KDKYADYSIPSCCQ-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- PNNGXMJMUUJHAV-UHFFFAOYSA-N icotinib hydrochloride Chemical compound Cl.C#CC1=CC=CC(NC=2C3=CC=4OCCOCCOCCOC=4C=C3N=CN=2)=C1 PNNGXMJMUUJHAV-UHFFFAOYSA-N 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- NBBJYMSMWIIQGU-UHFFFAOYSA-N propionic aldehyde Natural products CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000013037 reversible inhibitor Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/30—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds
- C07C209/32—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds by reduction of nitro groups
- C07C209/36—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds by reduction of nitro groups by reduction of nitro groups bound to carbon atoms of six-membered aromatic rings in presence of hydrogen-containing gases and a catalyst
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明公开了种间氨基苯乙炔的制备方法,将丙酮基膦酸二甲酯和对甲基苯磺酰叠氮在强碱性条件下反应得到(1‑重氮基‑2‑氧代丙基)膦酸二甲酯;然后将(1‑重氮基‑2‑氧代丙基)膦酸二甲酯和间硝基苯甲醛在碱性催化剂条件下反应得到间硝基苯乙炔;最后将间硝基苯乙炔经过还原得到间氨基苯乙炔。本发明的一个重要特征在于使用市场易得的原料间硝基苯甲醛,这样就避免了使用价格昂贵的原料间碘代硝基苯、间溴代硝基苯或间硝基苯乙炔,降低了生产成本。操作简单,不需要高压设备,不需要真空精馏,设备要求简单,节约成本,环境污染小,适合工业化生产。
Description
技术领域
本发明涉及一种间氨基苯乙炔的合成方法,属于有机化学和药物化学领域。
背景技术
间氨基苯乙炔,又名3-乙炔苯胺,有氨基和炔基两个官能团,可以衍生出一系列的重要中间体。结构式为:
间氨基苯乙炔本身具有很好的力学性能和很高的机械强度,可承受相当高的扭切力,且耐高温性能耐磨性能非常好,它和马来酸酐反应生成的聚酰亚胺类化合物极为重要,用这种聚合物制成的树脂具有很高的热稳定性和很高的机械强度,是一种用于合成航空、航天、军事等领域的高档树脂,可应用于飞机的尾翼和导弹的壳体;间氨基苯乙炔和喹唑啉化合物反应生成具有抗肿瘤活性的化合物,如埃克替尼、埃罗替尼等。新型抗癌药物为埃罗替尼(通用名:Erlotinib)的关键中间体。盐酸埃罗替尼由罗氏公司研发,是一种小分子表皮生长因子受体酪氨酸激酶可逆性抑制剂,2005年在美国上市,临床上主要用于局部晚期或转移性非小细胞肺癌二线或三线治疗和胰腺癌的治疗。最近已经被美国FDA批准可和吉西他滨联合作为晚期胰腺癌一线治疗。
目前,已知的式(Ⅰ)化合物制备方法主要有:
方法一:美国专利US20060224016、欧洲专利EP2433931中介绍以间卤代苯胺和2-甲基-3-丁炔-2-醇为起始原料,通过三苯基膦、乙酸钯和碘化亚铜催化下发生Sonogashira偶联反应生成1-(3-氨基苯基)-3-甲基-3-羟基-1-丁炔,再在强碱条件下加热发生消除反应得到目标产物。该方法用到价格昂贵的钯催化剂,且消除反应需加热进行,会产生大量聚合反应副产物,收率较低(文献报道66%,重复试验远低于报道值),故不适宜工业化生产。另外文献(Org.Bio.Chem.,2003,1:4441-4450;BeilsteinJ.Org.Chem.,2011,7:426-431)中分别报道了类似的以间溴或间卤代苯胺、间碘代硝基苯等和带保护的二羟基丙基炔为起始原料,也存在上述不利因素。
方法二:美国US4125563、US6127583以间硝基苯乙酮为起始原料,三氯氧磷和无水DMF混合制备成vilsmiere试剂,将间硝基苯乙酮分批加入,制得β-氯代间硝基苯丙醛,再经强碱消除制得间硝基苯乙炔,最后还原硝基制得间氨基苯乙炔。该方法第一步反应放热剧烈,很难控制,消除反应副反应较多,最后产品分离需精馏,收率较低,故不适宜工业化生产。
方法三:专利WO2007067506,文献(Tetrahedron,2008,64(44):10195-10200)中介绍以间硝基碘苯和三甲基硅基乙炔为原料,在双(三苯基膦)二氯化钯和碘化亚铜或氯化亚铜催化下偶联得到(3-硝基苯基)-(三甲基硅基)-乙炔,再在微波辐射下经六羰基钼/1,8-二氮杂环[5.4.0]十一-7烯(DBU)还原得到目标化合物。该法所用原料价格昂贵,操作繁琐,总收率67%左右。
方法四:上海应用技术学院申请的中国专利CN102775315A中介绍了一种制备方法,以间硝基苯甲醛为起始原料,首先在乙醇溶剂中与丙二酸通过碱性催化剂催化进行缩合,然后脱羧得到间硝基肉桂酸,进而再在醋酸溶液中溴化得α,β-二溴-3-(3’-硝基苯基)丙酸,后通过弱碱脱羧及选择性脱溴,制得(Z)-1-(2-溴乙稀)-3-硝基苯,再经强碱完全脱溴制得间炔基硝基苯,最后经铁粉还原并进一步精馏纯化得间氨基苯乙炔。共五步反应,选择性脱溴过程反应条件很难控制,会产生大量反应副产物,另外最后需要高真空精馏,对设备要求高,收率较低58%,从而造成产品成本较高,故不适宜工业化生产。另外中国专利CN1313274中介绍以间炔基硝基苯为起始原料,直接还原得到间氨基苯乙炔,存在原料不易得到。
方法五:文献
(HuaxueShijie,2011,52:423-426;Chem.Lett.,2005,34:28-29;TetrahedronLett.,2011,52:2394-2396)等中介绍了以α,β-二溴-3-(3’-硝基苯基)丙酸为原料,通过碱性条件下消除反应得间硝基苯乙炔,而后经还原得间氨基苯乙炔。此路线简单经济,但是根据目前文献报道的方法存在着消除副反应较难控制,副产物多且需要利用微波促进脱卤反应等因素限制了该路线的工业化使用。
方法六:浙江理工大学张俊等在文献
(ChineseJournalofPharmaceuticals.2012,43(10),812-814)中介绍以间硝基苯甲醛为起始原料,先通过Perkin反应生成间硝基肉桂酸,再经溴加成制得2,3-二溴-3-(3-硝基苯基)丙酸,然后同时脱溴化氢和羧基得(Z)-1-溴-2-(3-硝基苯)乙稀,再氢化钠脱溴化氢得间硝基苯乙炔,最后经铁粉还原得到间氨基苯乙炔。该方法原料易得,共五步反应,但是选择性脱溴过程反应条件很难控制,会产生大量反应副产物,收率较低45%,从而造成产品成本较高,故不适宜工业化生产。
发明内容
本发明所要解决的技术问题在于提供一种起始原料方便易得、工艺路线简便合理,成本低、三废污染小,能在大规模生产,产品质量好,收率高的间氨基苯乙炔的制备方法
本发明的技术方案如下:一种间氨基苯乙炔的合成方法,将丙酮基膦酸二甲酯和对甲基苯磺酰叠氮在强碱性条件下反应得到(1-重氮基-2-氧代丙基)膦酸二甲酯;然后将(1-重氮基-2-氧代丙基)膦酸二甲酯和间硝基苯甲醛在碱性催化剂条件下反应得到间硝基苯乙炔;最后将间硝基苯乙炔经过还原得到间氨基苯乙炔。
本发明采用已经商业化的间硝基苯甲醛为起始原料,与(1-重氮基-2-氧代丙基)膦酸二甲酯(Bestmann-Ohira试剂)发生Seyferth–Gilbert增碳反应,即(1-重氮基-2-氧代丙基)膦酸二甲酯(Bestmann-Ohira试剂)被碱去质子化,生成碳负离子,并对酮羰基进行亲核加成,生成的烷氧基负离子再分子内进攻磷原子,环化生成恶磷杂丁环,然后开环,放出磷酸二甲酯,并产生乙烯基重氮化合物,后者最后放出氮气,得乙烯基卡宾,并发生1,2-迁移,得最终产物间硝基苯乙炔,再经还原硝基制得间氨基苯乙炔,整个反应过程简便高效,反应条件温和,收率可达80%以上,原材料易得,成本大大降低,高效、操作简单污染小,适宜工业化生产。
本发明的具体操作步骤为:
(1)、将丙酮基膦酸二甲酯在反应溶剂和强碱作用下,与对甲基苯磺酰叠氮反应制得(1-重氮基-2-氧代丙基)膦酸二甲酯;
(2)、步骤(1)所得(1-重氮基-2-氧代丙基)膦酸二甲酯粗品不需纯化,直接与起始原料间硝基苯甲醛在碱性催化剂下反应,制得间硝基苯乙炔;
所述的碱性催化剂为碳酸钾或碳酸钠或碳酸氢钠或叔丁醇钾或甲醇钠或乙醇钠;
所述间硝基苯甲醛:碱性催化剂:(1-重氮基-2-氧代丙基)膦酸二甲酯的摩尔比为1:1.5~4.0:1~1.5,其中(1-重氮基-2-氧代丙基)膦酸二甲酯按折纯后算;
(3)、步骤(2)所得间硝基苯乙炔经还原,再经纯化,最终制得目标产物间氨基苯乙炔;反应方程式为:
在上述技术方案中:所述步骤(1)中的反应溶剂为苯或甲苯或四氢呋喃;所述的强碱为氢氧化钾或氢化钠或氢化钙;配料比按摩尔比计算为丙酮基磷酸二甲酯:强碱:对甲基苯磺酰叠氮为1:1~1.2:1~1.2。
在上述技术方案中:所述步骤(2)中所用反应溶剂为甲醇或乙醇或乙腈或四氢呋喃或N,N-二甲基甲酰胺。
在上述技术方案中:采用铁粉或钯碳或RannyNi加氢还原或氯化亚锡还原方法还原间硝基苯甲醛。
在上述技术方案中:所述间硝基苯甲醛采用铁粉还原。铁粉便宜,易得。
在上述技术方案中:所述间硝基苯乙炔经铁粉,在反应溶剂和电解质存在条件下进行还原后,再经纯化,最终制得目标产物间氨基苯乙炔;所述反应溶剂为甲醇或乙醇或异丙醇;所述电解质为氯化钠或氯化铵或醋酸或稀盐酸;原料的配料比按摩尔比计算为间硝基苯乙炔:铁粉:氯化铵为1:3.5~6:0.05~0.1,常压下控制反应温度在50~80℃,反应时间2~6h。
有益效果:与现有技术相比,本发明具有以下优点:
(1)、本发明的一个重要特征在于使用市场易得的原料间硝基苯甲醛,这样就避免了使用价格昂贵的原料间碘代硝基苯、间溴代硝基苯或间硝基苯乙炔,降低了生产成本。
(2)、本发明操作简单,不需要高压设备,不需要真空精馏,设备要求简单,节约成本,环境污染小,适合工业化生产。
具体实施方式
下面结合实施例对本发明作进一步说明:
实施例1
(1-重氮基-2-氧代丙基)膦酸二甲酯(Bestmann-Ohira试剂)的制备。在1000ml反应瓶中依次加入丙酮基磷酸二甲酯33.2g(0.2mol)和300ml甲苯,分批次加入NaH5.1g(0.21mol),待气体全部放完,将对甲基苯磺酰叠氮41.4g(0.21mol)和500ml四氢呋喃混合液加入到反应液中,室温下反应16h。反应完后,加入石油醚稀释,过滤,滤饼用乙醚洗,减压蒸除溶剂,得到黄色液体33.1g,收率86.5%。
实施例2
(1-重氮基-2-氧代丙基)膦酸二甲酯(Bestmann-Ohira试剂)的制备。在1000ml反应瓶中依次加入丙酮基磷酸二甲酯33.2g(0.2mol)和300ml四氢呋喃,分批次加入氢化钠8g(0.2mol),待气体全部放完,将对甲基苯磺酰叠氮47.3g(0.24mol)和500ml四氢呋喃混合液加入到反应液中,室温下反应12h。反应完后,加入石油醚稀释,过滤,滤饼用乙醚洗,减压蒸除溶剂,得到黄色液体33.7g,收率88%。
实施例3
间硝基苯乙炔的制备。在干燥洁净的1000ml反应瓶中依次加入间硝基苯甲醛15.1g(0.1mol)、自制(1-重氮基-2-氧代丙基)膦酸二甲酯(Bestmann-Ohira试剂)18.3g(0.11mol)(折纯后)和750ml甲醇,冷却至0~5℃,缓慢加入无水碳酸钾20.7g(0.15mol),加料时控制温度为0-5℃,加毕,保温搅拌2h。然后将反应温度升至室温,继续搅拌反应8h。停止反应,加饱和氯化铵水溶液,二氯甲烷150ml×3萃取,合并有机相,无水硫酸钠干燥2h。过滤,适量二氯甲烷洗涤滤饼,合并有机相,减压浓缩回收溶剂,冷冻固化得淡黄色固体13.1g,收率为89.2%。
实施例4
间硝基苯乙炔的制备。在干燥洁净的1000ml反应瓶中依次加入间硝基苯甲醛15.1g(0.1mol)、自制(1-重氮基-2-氧代丙基)膦酸二甲酯(Bestmann-Ohira试剂)24.9g(0.15mol)和750ml乙腈,冷却至0~5℃,缓慢加入无水碳酸钠42.4g(0.4mol),加料时控制温度为0-5℃,加毕,保温搅拌2h。然后将反应温度升至室温,继续搅拌反应8h。停止反应,加饱和氯化铵水溶液,二氯甲烷150ml×3萃取,合并有机相,无水硫酸钠干燥2h。过滤,适量二氯甲烷洗涤滤饼,合并有机相,减压浓缩回收溶剂,冷冻固化得淡黄色固体13.4g,收率为91.3%。
Claims (6)
1.一种间氨基苯乙炔的合成方法,将丙酮基膦酸二甲酯和对甲基苯磺酰叠氮在强碱性条件下反应得到(1-重氮基-2-氧代丙基)膦酸二甲酯;然后将(1-重氮基-2-氧代丙基)膦酸二甲酯和间硝基苯甲醛在碱性催化剂条件下反应得到间硝基苯乙炔;最后将间硝基苯乙炔经过还原得到间氨基苯乙炔。
2.根据权利要求1所述间氨基苯乙炔的制备方法,其特征在于:具体操作步骤为:(1)、将丙酮基膦酸二甲酯在反应溶剂和强碱作用下,与对甲基苯磺酰叠氮反应制得(1-重氮基-2-氧代丙基)膦酸二甲酯;(2)、步骤(1)所得(1-重氮基-2-氧代丙基)膦酸二甲酯粗品不需纯化,直接与起始原料间硝基苯甲醛在碱性催化剂下反应,制得间硝基苯乙炔;所述的碱性催化剂为碳酸钾或碳酸钠或碳酸氢钠或叔丁醇钾或甲醇钠或乙醇钠;所述间硝基苯甲醛:碱性催化剂:(1-重氮基-2-氧代丙基)膦酸二甲酯的摩尔比为1:1.5~4.0:1~1.5,其中(1-重氮基-2-氧代丙基)膦酸二甲酯按折纯后算;(3)、步骤(2)所得间硝基苯乙炔经还原,再经纯化,最终制得目标产物间氨基苯乙炔。
3.根据权利要求2所述间氨基苯乙炔的制备方法,其特征在于:所述步骤(1)中的反应溶剂为苯或甲苯或四氢呋喃;所述的强碱为氢氧化钾或氢化钠或氢化钙;配料比按摩尔比计算为丙酮基磷酸二甲酯:强0碱:对甲基苯磺酰叠氮为1:1~1.2:1~1.2。
4.根据权利要求2所述间氨基苯乙炔的制备方法,其特征在于:所述步骤(2)中所用反应溶剂为甲醇或乙醇或乙腈或四氢呋喃或N,N-二甲基甲酰胺。
5.根据权利要求2所述间氨基苯乙炔的制备方法,其特征在于:所述步骤(3)中:采用铁粉或钯碳或RannyNi加氢还原或氯化亚锡还原方法还原间硝基苯甲醛;所述间硝基苯甲醛采用铁粉还原。
6.根据权利要求5所述间氨基苯乙炔的制备方法,其特征在于:所述间硝基苯乙炔经铁粉,在反应溶剂和电解质存在条件下进行还原后,再经纯化,最终制得目标产物间氨基苯乙炔;所述反应溶剂为甲醇或乙醇或异丙醇;所述电解质为氯化钠或氯化铵或醋酸或稀盐酸;原料的配料比按摩尔比计算为间硝基苯乙炔:铁粉:氯化铵为1:3.5~6:0.05~0.1,常压下控制反应温度在50~80℃,反应时间2~6h。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710140835.0A CN108569969A (zh) | 2017-03-10 | 2017-03-10 | 一种间氨基苯乙炔的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710140835.0A CN108569969A (zh) | 2017-03-10 | 2017-03-10 | 一种间氨基苯乙炔的合成方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108569969A true CN108569969A (zh) | 2018-09-25 |
Family
ID=63578016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710140835.0A Withdrawn CN108569969A (zh) | 2017-03-10 | 2017-03-10 | 一种间氨基苯乙炔的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108569969A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112851527A (zh) * | 2020-12-31 | 2021-05-28 | 湖北英纳氏生物科技有限公司 | 间氨基苯乙炔的制备方法 |
-
2017
- 2017-03-10 CN CN201710140835.0A patent/CN108569969A/zh not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112851527A (zh) * | 2020-12-31 | 2021-05-28 | 湖北英纳氏生物科技有限公司 | 间氨基苯乙炔的制备方法 |
CN112851527B (zh) * | 2020-12-31 | 2022-11-01 | 湖北英纳氏生物科技有限公司 | 间氨基苯乙炔的制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101429115B (zh) | 三氟苯乙酸和西他列汀的制备方法 | |
CN106187808A (zh) | Ahu-377的制备方法、ahu-377中间体及ahu-377中间体的制备方法 | |
CN110372578A (zh) | 一种新的马来酸氯苯那敏合成方法 | |
CN108276287A (zh) | 一种可见光催化的4-氧代丙烯酸酯类衍生物的合成方法 | |
CN110950765A (zh) | 一种硫酸特布他林的制备方法 | |
CN101891621A (zh) | 3-乙氧基-4-乙氧羰基苯乙酸的合成方法 | |
CN110590569B (zh) | 一种合成妥洛特罗的方法 | |
CN114539048B (zh) | 一种卡龙酸酐中间体及卡龙酸酐的制备方法 | |
CN108569969A (zh) | 一种间氨基苯乙炔的合成方法 | |
CN102381918B (zh) | 一种由苄氯类化合物合成苯乙腈类化合物的方法 | |
CN116693420B (zh) | 液相制备七氟异丁腈的方法 | |
CN113636939A (zh) | 一种4,4`-二硝基联苄的制备方法 | |
CN102020543B (zh) | 一种生产9-芴酮的方法 | |
CN102718624B (zh) | 一种三苯基氯甲烷的合成方法 | |
CN101100450A (zh) | 乙磺酰基乙腈的制备方法 | |
CN109053495B (zh) | 一种lcz696中间体的合成方法 | |
CN103724211A (zh) | 间氨基苯乙炔的制备方法 | |
Genovese et al. | Ytterbium triflate catalyzed synthesis of chlorinated lactones | |
CN101538253B (zh) | 一种制备瑞格列奈中间体的方法 | |
CN112778109B (zh) | 1-[3-氯-5-(三氟甲基)苯基]-2,2,2-三氟乙酮及其衍生物的制备方法 | |
CN113698274B (zh) | 一种高收率合成3-丁炔-2-醇的方法 | |
CN102816071B (zh) | 一种n-乙基乙二胺的合成方法 | |
CN107445835B (zh) | 一种1,2-二氢环丁烯并[a]萘衍生物及其前体的合成方法 | |
CN101245045A (zh) | 一种吲哚-4-甲醛的合成方法 | |
CN108863900A (zh) | 一种5-氟吲哚-2-酮的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180925 |